Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:42 pm Purchase | 2025-06-30 | 13G | Xilio Therapeutics, Inc. XLO | GILEAD SCIENCES INC. GILD | 10,613,944 19.900% | 1,508,493 (+16.57%) | Filing History |
| 2025-08-14 1:47 pm Purchase | 2025-06-30 | 13G | Xilio Therapeutics, Inc. XLO | Frazier Life Sciences Public Fund, L.P. | 8,141,017 9.900% | 2,393,824 (+41.65%) | Filing History |
| 2025-06-17 5:28 pm Purchase | 2025-06-05 | 13G | Xilio Therapeutics, Inc. XLO | Point72 Asset Management, L.P. | 4,000,000 7.200% | 4,000,000 (New Position) | Filing History |
| 2025-06-12 4:55 pm Purchase | 2025-06-05 | 13G | Xilio Therapeutics, Inc. XLO | Frazier Life Sciences Public Fund, L.P. | 5,747,193 9.900% | 5,747,193 (New Position) | Filing History |
| 2025-05-15 10:48 am Sale | 2025-03-31 | 13G | Xilio Therapeutics, Inc. XLO | Rock Springs Capital Management LP | 0 0.000% | -3,003,259 (Position Closed) | Filing History |
| 2025-02-18 4:15 pm Purchase | 2025-02-11 | 13G | Xilio Therapeutics, Inc. XLO | AbbVie Inc. ABBV | 4,347,826 9.000% | 4,347,826 (New Position) | Filing History |
| 2024-12-19 4:15 pm Purchase | 2024-12-18 | 13G | Xilio Therapeutics, Inc. XLO | GILEAD SCIENCES INC. GILD | 9,105,451 19.900% | 1,759,978 (+23.96%) | Filing History |
| 2024-11-14 5:44 pm Purchase | 2024-09-30 | 13G | Xilio Therapeutics, Inc. XLO | Bain Capital Life Sciences Fund II, L.P. | 4,566,817 11.000% | 3,218,135 (+238.61%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | Xilio Therapeutics, Inc. XLO | Atlas Venture Fund XI, L.P. | 0 0.000% | -2,023,402 (Position Closed) | Filing History |
| 2024-11-12 4:50 pm Unchanged | 2024-09-30 | 13G | Xilio Therapeutics, Inc. XLO | Rock Springs Capital Management LP | 3,003,259 6.830% | 0 (Unchanged) | Filing History |
| 2024-11-12 10:40 am Sale | 2024-11-08 | 13G | Xilio Therapeutics, Inc. XLO | FMR LLC | 1,395,853 3.175% | -511,818 (-26.83%) | Filing History |
| 2024-09-27 9:36 pm Purchase | 2024-06-07 | 13G | Xilio Therapeutics, Inc. XLO | GKCC, LLC | 7,000,000 15.900% | 7,000,000 (New Position) | Filing History |
| 2024-07-31 07:46 am Unchanged | 2024-07-31 | 13G | Xilio Therapeutics, Inc. XLO | Takeda Pharmaceutical Company Limited | 1,475,121 4.000% | 0 (Unchanged) | Filing History |
| 2024-04-05 4:31 pm Purchase | 2024-03-27 | 13G | Xilio Therapeutics, Inc. XLO | GILEAD SCIENCES INC. GILD | 7,345,473 19.900% | 7,345,473 (New Position) | Filing History |
| 2024-04-05 2:51 pm Purchase | 2024-03-27 | 13G | Xilio Therapeutics, Inc. XLO | Rock Springs Capital Management LP | 3,003,259 8.710% | 3,003,259 (New Position) | Filing History |
| 2024-02-14 2:12 pm Purchase | 2023-12-31 | 13G | Compass Therapeutics, Inc. CMPX | Rock Springs Capital Management LP | 1,440,759 5.230% | 1,440,759 (New Position) | Filing History |
| 2024-02-06 4:04 pm Sale | 2024-01-02 | 13G | Xilio Therapeutics, Inc. XLO | Octagon Capital Advisors LP | 0 0.000% | -1,785,000 (Position Closed) | Filing History |
| 2024-02-05 4:01 pm Sale | 2023-12-31 | 13G | Xilio Therapeutics, Inc. XLO | Octagon Capital Advisors LP | 1,785,000 6.480% | -640,000 (-26.39%) | Filing History |
| 2023-04-10 4:57 pm Purchase | 2023-03-30 | 13G | Xilio Therapeutics, Inc. XLO | MRL Ventures Fund LLC | 1,483,414 5.400% | 1,483,414 (New Position) | Filing History |
| 2023-02-09 08:14 am Sale | 2023-02-09 | 13G | Xilio Therapeutics, Inc. XLO | FMR LLC | 1,907,671 6.944% | -662,599 (-25.78%) | Filing History |